ILMNvs its industry peers
A metric-by-metric comparison of ILMN against iShares Biotechnology ETF holdings — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ILMN본 종목 | $33.6B#5 | 41.5x#4 | 11.8x#3 | 7.7x#4 | -0.7%#6 | 169.5%#4 | 18.6%#5 | 30.0%#3 | 22.0%#4 | 7#1 | — | — |
| VRTX | $130.4B#3 | 30.0x#3 | 6.4x#2 | 10.9x#5 | 8.9%#4 | 838.1%#3 | 34.8%#1 | 19.5%#5 | 25.0%#3 | — | — | — |
| AMGN | $203.1B#1 | 23.3x#2 | 17.4x#5 | 5.5x#2 | 10.0%#3 | 88.5%#5 | 24.7%#4 | 66.0%#2 | 15.1%#5 | — | 40.3%#2 | 2.5%#1 |
| GILD | $181.4B#2 | — | 15.3x#4 | 6.2x#3 | 2.4%#5 | 1672.9%#2 | 34.0%#2 | 71.9%#1 | 26.7%#2 | — | 32.9%#3 | 2.2%#2 |
| NTRA | $50.6B#4 | — | 27.8x#6 | 21.9x#6 | 35.9%#1 | -9.3%#6 | -13.4%#6 | -11.4%#6 | -18.0%#6 | — | — | — |
| INCY | $24.3B#6 | 17.2x#1 | 4.3x#1 | 4.7x#1 | 21.2%#2 | 3846.9%#1 | 29.5%#3 | 22.9%#4 | 49.0%#1 | — | 46.4%#1 | — |
Peer set: top holdings of IBB (iShares Biotechnology ETF), the indexed fund holding this stock at its highest weight — a fund manager's grouping, not Tickwind's judgement. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-09-16.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice